您的位置: 首页 > 农业专利 > 详情页

Novel combination treatment of cancer
专利权人:
发明人:
申请号:
EP11161593.6
公开号:
EP2508176A1
申请日:
2011.04.08
申请国别(地区):
EP
年份:
2012
代理人:
摘要:
The present invention relates combination treatments in cancer therapy. Specifically, it provides the combination of EGFR-targeted immunoliposomes and colony-stimulating factors. The immunoliposomes preferably comprise an encapsulated cytostatic agent and an EGFR-targeting ligand such as an antibody, antibody fragment, or conjugate thereof. The colony-stimulating factors are selected from the group of granulocyte colony-stimulating factors, such as filgrastim, lenograstim, or pegfilgrastim. The immunoliposomes and the colony-stimulating factor may be administered separately or in a single composition.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充